[1]鞠永健.90Y微球治疗肝癌的剂量估算方法现状[J].国际放射医学核医学杂志,2002,26(3):134-136.
　JU Yong-jian.The methods of dose estimation about the treatment with 90Y-microspheres in liver malignancy[J].International Journal of Radiation Medicine and Nuclear Medicine,2002,26(3):134-136.
点击复制

90Y微球治疗肝癌的剂量估算方法现状(/HTML)
分享到：

《国际放射医学核医学杂志》[ISSN:1673-4114/CN:12-1381/R]

卷:
26
期数:
2002年第3期
页码:
134-136
栏目:
综述
出版日期:
1900-01-01

文章信息/Info

Title:
The methods of dose estimation about the treatment with 90Y-microspheres in liver malignancy
作者:
鞠永健
300192 天津, 中国医学科学院中国协和医科大学放射医学研究所
Author(s):
JU Yong-jian
The Institute of Radiation Medicine, Chinese Academy of Medical Science, Peking Union Medical College, Tianjin 300192, China
关键词:
90Y-微球; 肝癌; 辐射剂量; 经肝动脉灌注治疗; 瘤内注入治
Keywords:
90Y-microspheres; liver malignancy; radiation dose; intraarterial infusion therapy; intratumoral delivery therapy
分类号:
R817.5;R144.1
摘要:
在肝癌的姑息治疗方法中,由于用90Y标记的微球治疗能给予肿瘤部位足够的致死剂量又使正常肝脏组织不超过其耐受剂量,所以在临床上得到了广泛的应用。本文介绍了使用90Y-微球治疗肝癌的方法及病人正常组织和肿瘤组织的剂量估算方法。
Abstract:
In the palliative methods of liver malignancy treatment,using 90Y-microspheres therapy can deliver the tu-moricidal dose to the tumor whilst sparing the normal tissue,so It has been used widely in clinics.This article will summarize the liver malignancy treatment methods with 90Y-microspheres and the relative dose calculating methods.

参考文献/References:

[1] Dancey JE,Shepherd FA,Paul K. Treatment of nonresectable hepatocellular carcinoma with intrahepatic 90Y-microspheres[J].Journal of Nuclear Medicine,2000,(41):1673-1681.
[2] Johnson PJ. Editorial:Why can’t we cure primary liver can cer?[J].European Journal of Cancer,1995.1562-1564.
[3] Lau WY,Leung TWT,Ho S. Treatment of inoperable hepatocellular carcinoma with intrahepatic arterial yttrium90 microspheres:a phase Ⅰ and Ⅱ study[J].British Journal of Cancer,1994.994-999.
[4] HOS,Lau WY,Leung TWT. Internal radiation therapy for patients with primary or metastatic hepatic cancer[J].Cancer,1998,(9):1894-1907.
[5] HOS,Lau WY,Leung TWT. Clinical evaluation of partition model for estimating radiation doses from yttrium-90 microspheres in the treatment of hepatic cancer[J].European Journal of Nuclear Medicine,1997.293-298.
[6] Andrews JC,Walker SC,Ackermann RJ. Hepatic radioembolization with yttrium-90 containing glass microspheres:primary results and clinical follow-up[J].Journal of Nuclear Medicine,1994.1637-1644.
[7] Lau WY,Ho S,Leung TWT. Selective internal radia tion therapy for nonresectable hepatocellular carcinoma with intraarterial infusion of 90Y microspheres[J].International Journal of Radiation Oncology,Biology,Physics,1998,(40):583-592.
[8] Lin WY,Tsai SC,Hsieh JF. Effects of 90Y-microspheres on liver tumors:comparison of intratumoral injection methods and intra-arterial injection method[J].Journal of Nuclear Medicine,2000.1892-1897.
[9] HOS,Lau WY,Leung TWT. Tumour-to-normal uptake ratio of 90Y microspheres in hepatic cancer assessed with ~(99)Tc~m macroaggregated albumin[J].British Journal of Radiology,1997,(70):823-828.
[10] HOS,Lau WY,Leung TWT. Partition model for estimating doses from yttrium-90 microspheres in treating hepatic tumours[J].EUROPEAN JOURNAL OF NUCLEAR MEDICINE,1996.947-952.
[11] Campbell AM,Bailey IH,Burton MA. Analysis of distribution of intra-arterial micro-spheres in human liver following hepatic yttrium-90 microspheres therapy[J].Physics in Medicine and Biology,2000,(4):1023-1033.
[12] Wessels BW,Siegel SA. Dosimetry overview:keeping score on the scorekeerpers[J].Cancer,1997,(zk):2501-2504.
[13] Tian JH,Xu BX,Zhang JM. Ultrasound-guided internal radiotherapy using yttrium-90-glass microspheres for liver malignancies[J].Journal of Nuclear Medicine,1996.958-963.
[14] HOS,Lau WY,Leung TWT. Comments on Ultrasound guided internal radiotherapy using yttrium-90 glass microspheres for liver malignancies[J].Journal of Nuclear Medicine,1997.1169.

相似文献/References:

[1]吴震宇.核素显像在肝癌临床诊断中的应用[J].国际放射医学核医学杂志,2004,28(5):199.
　WU Zhen-yu.The clinical application of nuclein scanning in liver carcinoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2004,28(3):199.
[2]温广华.18F-FDG PET显像在肝癌中的应用[J].国际放射医学核医学杂志,2003,27(1):21.
　WEN Guang-hua.The applications of 18F-FDG PET in liver carcinoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2003,27(3):21.
[3]童冠圣.核素标记微球治疗肝癌的实验与临床研究[J].国际放射医学核医学杂志,2000,24(3):116.
　TONG Guan-sheng.Experimental and clinical study on radionuclide-lablled microspheres in treating hepatic cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2000,24(3):116.
[4]傅尚志,张楚毅.肝癌内照射临床及实验研究进展[J].国际放射医学核医学杂志,1996,20(5):202.

备注/Memo

备注/Memo:
收稿日期:2001-8-16。
作者简介:鞠永健(1973-),男,江苏泰兴人,博士研究生,主要从事内辐射治疗后核素分布、剂量计算及肿瘤控制概率计算模型方面的研究。
更新日期/Last Update: 1900-01-01